Articles published in Metabolomics:Open Access have been cited by esteemed scholars and scientists all around the world.
Metabolomics:Open Access has got h-index 14, which means every article in Metabolomics:Open Access has got 14 average citations.
Following are the list of articles that have cited the articles published in Metabolomics:Open Access.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total published articles |
20 | 15 | 20 | 30 | 24 | 7 | 9 |
Research, Review articles and Editorials |
0 | 0 | 0 | 1 | 2 | 0 | 5 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 15 | 20 | 29 | 22 | 7 | 4 |
Conference proceedings |
0 | 0 | 8 | 2 | 2 | 45 | 48 |
Citations received as per Google Scholar, other indexing platforms and portals |
959 | 691 | 102 | 110 | 105 | 105 | 96 |
Journal total citations count | 895 |
Journal impact factor | 1.8 |
Journal 5 years impact factor | 3.73 |
Journal cite score | 2.25 |
Journal h-index | 14 |
Journal h-index since 2019 | 9 |
Berezin A (2016) Is the neutrophil extracellular trap-driven microvascular inflammation essential for diabetes vasculopathy?. Biomedical Research and Therapy 3: 1-7. |
|
van Ravenzwaay B, Sperber S, Lemke O, Fabian E, Faulhammer F, et al. (2016) Metabolomics as read-across tool: A case study with phenoxy herbicides. Regulatory Toxicology and Pharmacology 81: 288-304. |
|
Seliya B. Research and Reviews: Journal of Zoological Science Pp: s1-s6. |
|
Chekhun VF, Lozovska YV, Naleskina LA, Borikun TV, Burlaka AP, et al. (2016) Modifying effects of 5-azacytidine on metal-containing proteins profile in Guerin carcinoma with different sensitivity to cytostatics. Experimental oncology 38: 283. |
|
Cacabelos R (2016) Epigenetics of Brain Disorders: The Paradigm of Alzheimer’s Disease. J Alzheimers Dis Parkinsonism 6: 2161-0460. |
|
Cacabelos R, Torrellas C, Teijido O, Carril JC (2016) Pharmacogenetic considerations in the treatment of Alzheimer's disease. Pharmacogenomics 17: 1041-1074. |
|
Ma X, Guo X, Song Y, Qiao L, Wang W, et al. (2016) An Integrated Strategy for Global Qualitative and Quantitative Profiling of Traditional Chinese Medicine Formulas: Baoyuan Decoction as a Case. Scientific Reports. |
|
Yuk J, Patel DN, Isaac G, Smith K, Wrona M, et al. (2016) Chemical Profiling of Ginseng Species and Ginseng Herbal Products Using UPLC/QTOF-MS. Journal of the Brazilian Chemical Society 27: 1476-1483. |
|
Qiu S, Yang WZ, Yao CL, Qiu ZD, Shi XJ, et al. (2016) Nontargeted metabolomic analysis and “commercial-homophyletic†comparison-induced biomarkers verification for the systematic chemical differentiation of five different parts of Panax ginseng. Journal of Chromatography A 1453: 78-87. |
|
Ponting DJ, Murray E, Long A (2017)Quantifying confidence in the reporting of metabolic biotransformations. Drug Discovery Today |
|
Kao D, Ismond KP, Tso V, Millan B, Hotte N, et al. (2016) Urine-based metabolomic analysis of patients with Clostridium difficile infection: a pilot study. Metabolomics 12: 135. |
|
FitzGerald KE, Konduri PC, Vidal C, Yoo H, Zhang L (2017) The Bioenergetic Role of Mitochondria in Lung Cancer. InA Global Scientific Vision-Prevention, Diagnosis, and Treatment of Lung Cancer 2017. InTech. |
|
Alam MM, Lal S, FitzGerald KE, Zhang L (2016) A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors. Clinical and translational medicine 5: 3. |
|
Dey P, Dutta S, Chowdhury A, Das AP, Chaudhuri TK (2017) Variation in Phytochemical Composition Reveals Distinct Divergence of Aloe vera (L.) Burm. f. From Other Aloe Species: Rationale Behind Selective Preference of Aloe vera in Nutritional and Therapeutic Use. Journal of Evidence-Based Complementary & Alternative Medicine :2156587217698292. |
|
Cacabelos R (2016) Epigenetics of Brain Disorders: The Paradigm of Alzheimer’s Disease. J Alzheimers Dis Parkinsonism 6: 2161-0460. |
|
Cacabelos R, Torrellas C, Teijido O, Carril JC (2016) Pharmacogenetic considerations in the treatment of Alzheimer's disease. Pharmacogenomics 17: 1041-1074. |
|
Cacabelos R (2015) Impact of genomic medicine on the future of Neuropsychopharmacology. J Neuropsychopharmacol Mental Health 1. |
|
Cacabelos R, Torrellas C (2015) Epigenetics of aging and Alzheimer’s disease: Implications for pharmacogenomics and drug response. International journal of molecular sciences 16: 30483-30543. |
|
Lu DY, Lu TR, Lu Y, Sastry N, Wu HY (2016) Discover Natural Chemical Drugs in Modern Medicines. Metabolomics (Los Angel) 6: 2153-0769. |
|
Lu DY, Lu TR, Xu B, Qi RX, S Yarla N, et al. (2016) Cancer Metastasis, a Clinical Dilemma for Therapeutics. Current Drug Therapy 11: 163-169. |
|
Metabolomics:Open Access received 895 citations as per Google Scholar report